Skip to Main

Molecular and Translational Nanomedicine

molecular nanomedicine image

The Molecular and Translational Nanomedicine (MTN) track is designed for students who are interested in molecular design of nanomedicine platforms to help translate basic biological science to clinical medicine. MTN is ideally suited for students with strong engineering, physical science, or biology background and a keen desire to cross the boundaries between traditional scientific disciplines. For more details, review the Molecular and Translational Nanomedicine Degree Plan.

Research Topics

Faculty members in the MTN track are from a diverse scientific, engineering, and clinical background to offer a highly interdisciplinary training environment. Molecular design and nano engineering are closely integrated with pathophysiology and biology rationales to establish emerging precision paradigms for disease diagnosis and therapy. Examples include:

  • Nano delineation of tumor boundaries for image-guided cancer surgery
  • Minimalist nanovaccine for immunotherapy
  • Theranostic nanomedicine integrating imaging and therapeutic delivery targeting diabetes or cancer
  • Cancer-targeted siRNA/miRNA delivery and therapy

Track Director

Ian Corbin, Ph.D.
Ian Corbin, Ph.D.

Associate Professor

Research Interests: Nanomedicine and image-guided drug delivery for novel diagnostic and therapeutic applications in oncology

Faculty

Jinming Gao, Ph.D.

Professor

Research Interests: Activatable optical/MRI imaging probes to study tumor metabolism and theranostic nanomedicine for cancer-targeted drug therapy

Jinming Gao, Ph.D.
Caroline de Gracia Lux, Ph.D.

Assistant Professor

Research Interests: Ultrasound contrast agent, perfluorocarbon emulsions, development of new ultrasound-based strategies for early detection and treatment of diseases

Caroline de Gracia Lux, Ph.D.
Jacques Lux, Ph.D.

Associate Professor

Research Interests: Bioresponsive nanomaterials for in vivo detection and therapy; targeted and activatable ultrasound agents for the detection of inflammation and cancer; ultrasound-based gene delivery platforms

Jacques Lux, Ph.D.
Ralph P. Mason, Ph.D., C.Sci., C.Chem.

Professor

Research Interests: Tumor pathophysiology, development of novel therapeutics and prognostic imaging biomarkers based on MRI, optical and photoacoustic imaging.

Ralph Mason, Ph.D.
Daniel Siegwart, Ph.D.

Associate Professor

Research Interests: Polymer and materials chemistry, drug and gene delivery, RNAi, biomedical imaging, detection and treatment of cancer

Daniel Siegwart, Ph.D.
Baran Sumer, M.D.

Professor

Research Interests: Clinical application of nanoprobes with unique nanoscale behavior

Baran Sumer, M.D.
Xiankai Sun, Ph.D.

Professor

Research Interests: Development of PET, SPECT, and MRI imaging probes to assess biological abnormalities and evaluation of disease treatment

Xiankai Sun, Ph.D.
 

Associate Members

These faculty members do not accept graduate students. They participate in teaching, co-mentoring, exam and dissertation committees, and all other program activities.

Kareem Azab, Ph.D.

Associate Professor

Research Interests: Drug Resistance Mechanism, Drug Delivery Systems, Nanoparticles, Immunotherapy, Tissue Engineering

Kareem Azab, Ph.D.
Jeffrey Cadeddu, M.D.

Professor

Research Interests: Urology; laparoscopy, telesurgical mentoring

Jeffrey Cadeddu, M.D.
Zoltan Kovacs, Ph.D.

Associate Professor

Research Interests: Molecular and functional imaging, rational design of bifunctional ligands, targeted MRI contrast agents and radiopharmaceuticals

Zoltan Kovacs, Ph.D.
Jayanthi Lea, M.D.

Professor

Research Interests: Cervical cancer, developmental therapeutics, ovarian cancer, early detection of ovarian cancer

Jayanthi Lea, M.D.
Shaw-Wei Tsen, M.D., Ph.D.

Assistant Professor

Research Interests: Pathogen inactivation, cancer prevention, aging research                                                                                 

Shaw-Wei Tsen, M.D., Ph.D.